Patent · US Active

Substituted tetraarylbenzenes

US9231220B2 · kind B2 · utility

2Cited by

1References

14Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Rémi Mamouk Anémian · Seoul, KR
Aurélie Ludemann · Frankfurt, DE
Thomas Eberle · Landau, DE
Sigurd Hoeger · Bonn, DE
Eva Maria Reis · Höchst im Odenwald, DE
Vanessa Bobbe · Bonn, DE

Key dates

Filing date	Oct 30, 2014
Grant date	Jan 5, 2016
Priority date	—
Expiry date	Oct 30, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02E10/549
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to electronic devices comprising at least one compound of the formula (1)where X is N and Y is CR1, and to the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.